IGF1R and cancer: It is also implicated in anti-cancer drug resistance through several signaling pathways activated by BPA binding to nuclear and membrane receptors such as ERα/β/γ, androgen receptor, and insulin-like growth factor-1 receptor (IGF-1R), among others [10].